The Annexure

News to 16 October 2026 ·

Desk›Healthcare› Laurus Labs Ltd

Laurus Labs Ltd

BSE 540222 · NSE LAURUSLABS · ISIN INE947Q01028 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹1,935.30

+0.80%

BSE close, 28 August 2026

Market cap

₹104,566.62 cr

54.0 cr shares · Large cap

Free float

₹75,111.15 cr

as published

P/E · P/B

119.8× · 24.49×

EPS ₹16.15 · BV ₹79.02

FY25-26 rev / PAT

6,089.07 / 740.48

₹ cr, as filed

Filings, window

15

4 selected · 27%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹822.85 52-WK HIGH ₹1,939.00 ₹1,935.30 100% of range
Against 52-week high-0.2%
Against 52-week low+135.2%
Day change+0.80%
Size bandLarge cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹16.15
Price / earnings119.83×
Price / book24.49×
Book value — derived, price ÷ P/B₹79.02
Return on equity20.43%
Operating margin29.54%
Net margin16.50%

Consistency check

P/B ÷ P/E, which must equal ROE
20.44%
ROE as published
20.43%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 1,757.16 289.96 5.37 29.54% 16.50%
Mar-26 · Q 1,580.30 191.79 3.55 24.58% 12.14%
FY25-26 6,089.07 740.48 13.72 24.89% 12.16%

Quarter on quarter

Revenue, quarter on quarter
+11.2%
Net profit, quarter on quarter
+51.2%
Operating margin, quarter on quarter
+496 bps

Disclosure profile 15 filings in the window

0 median 17.0 p75 · 24 sector max 59 15 44th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 24 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Acquisition2
Concall Transcript1
Investor Presentation1
Selected sub-total4
Procedural
Analyst / Investor Meet5
General2
Board Meeting1
Compliance Certificate1
ESOP Allotment1
Trading Window1
Procedural sub-total11
Total15

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

15 filings · 4 selected · busiest 2026-10-13 and 2026-10-14

Filing rhythm · the twelve most recent

2026-08-122026-10-14

SelectedProcedural

Filings

15 in the window · 23 earlier on record

  1. 14 October 2026 ·

    General

    Intimation Of ESG Rating By CARE ESG Ratings Limited

    Please see annexed enclosure.

    Company Update / General View filing →

  2. 14 October 2026 ·

    Acquisition

    Updates on Acquisition

    Please see annexed enclosure.

    Company Update / Acquisition View filing →

  3. 13 October 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please see annexed enclosure.

    Company Update / Analyst / Investor Meet View filing →

  4. 13 October 2026 ·

    Board Meeting

    Board Meeting Intimation for Consideration Of The Un-Audited Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2026 And Payment Of Interim Dividend For FY 2026-27

    Laurus Labs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the un-audited financial results ....

    Board Meeting / Board Meeting View filing →

  5. 9 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please see annexed enclosure.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  6. 6 October 2026 ·

    Acquisition

    Updates on Acquisition

    Please see annexed enclosure.

    Company Update / Acquisition View filing →

  7. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Please see annexed enclosure.

    Insider Trading / SAST / Closure of Trading Window View filing →

  8. 18 September 2026 ·

    Investor Presentation

    Investor Presentation

    Please see attached enclosure.

    Company Update / Investor Presentation View filing →

  9. 15 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please see annexed enclosure.

    Company Update / Analyst / Investor Meet View filing →

  10. 10 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please see annexed enclosure.

    Company Update / Analyst / Investor Meet View filing →

  11. 31 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please see annexed enclosure.

    Company Update / Analyst / Investor Meet View filing →

  12. 12 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please see annexed enclosure.

    Company Update / Analyst / Investor Meet View filing →

  13. 10 August 2026 ·

    General

    Intimation Of ESG Score Given By NSE Sustainability Ratings And Analytics Limited

    Please see annexed enclosure.

    Company Update / General View filing →

  14. 30 July 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Please see annexed enclosure.

    Company Update / Earnings Call Transcript View filing →

  15. 27 July 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Please see annexed enclosure.

    Company Update / Allotment of ESOP / ESPS View filing →

RSS feed for Laurus Labs Ltd · the 50 most recent filings